Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 22, Number 8—August 2016

Research

Outbreak of Achromobacter xylosoxidans and Ochrobactrum anthropi Infections after Prostate Biopsies, France, 2014

Skerdi HaviariComments to Author , Pierre Cassier, Cédric Dananché, Monique Hulin, Olivier Dauwalder, Olivier Rouvière, Xavier Bertrand, Michel Perraud, Thomas Bénet, and Philippe Vanhems
Author affiliations: Hospices Civils de Lyon, Lyon, France (S. Haviari, P. Cassier, C. Dananché, M. Hulin, O. Dauwalder, O. Rouvière, M. Perraud, T. Bénet, P. Vanhems); Université Claude Bernard, Lyon (S. Haviari, P. Cassier, C. Dananché, O. Dauwalder, O. Rouvière, M. Perraud, T. Bénet, P. Vanhems); Centre International de Recherche en Infectiologie, Lyon (P. Cassier, O. Dauwalder, T. Bénet, P. Vanhems); Centre Hospitalier Régional Universitaire de Besançon, Besançon, France (X. Bertrand); Laboratoire des Pathogènes Émergents–Fondation Mérieux, Lyon (T. Bénet, P. Vanhems)

Main Article

Table 2

Characteristics and risk factors of patients and controls in the study of an outbreak of Achromobacter xylosoxidans and Ochrobactrum anthropi infections occurring after prostate biopsies, France, 2014*

Physiologic factors
Previously had biopsy 4 (50) 41 (82) 0.07 0.23 (0.044–1.08) –
Inflammatory histology 2 (25) 5 (10) 0.24 3.18 (0.373–17.9) –
Previous localized treatment** 0 10 (20) 0.33 0.23 (0.000–2.09) –
Neoplasic histology 5 (62.5) 41 (82) 0.34 0.36 (0.075–2.04) –

*HIFU, high-intensity focused ultrasound; OR, odds ratio; –, not included in the final multiple regression model.
†p values determined by using the Mann-Whitney U test.
‡For every additional 10 y in age, 5 µg/L (prostate-specific antigen), 20 mL (prostate size), and additional core (number of cores).
§n = 6 for cases, n = 44 for controls.
¶p values determined by using Fisher exact test.
#This variable was not included in the multiple model because it was closely correlated wtih the variable “first patient of the day.”
**Resection or HIFU.

Main Article

Page created: July 15, 2016
Page updated: July 15, 2016
Page reviewed: July 15, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external